RT @JoshuaDWallach: @Tufts_PACE @ESteyerberg Thanks for sharing - - we also observed that biological plausibility was rarely discussed in r…
@Tufts_PACE @ESteyerberg Thanks for sharing - - we also observed that biological plausibility was rarely discussed in reviews claiming sex differences. We have observed similar patterns for age (https://t.co/wLVEmMcKEm) and race (https://t.co/04cvbEjL6a)
Age-treatment Subgroup Analyses in Cochrane Intervention Reviews: A Meta-Epidemiological Study https://t.co/Fn53e3yT7H
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: W/ @YaleIMed's @jsross119, @UCSFMedicine's Sanket Dhruva, @METRICStanford's John Ioannidis, and @YaleDeptEHS's @vasilis…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: W/ @YaleIMed's @jsross119, @UCSFMedicine's Sanket Dhruva, @METRICStanford's John Ioannidis, and @YaleDeptEHS's @vasilis…
RT @JoshuaDWallach: W/ @YaleIMed's @jsross119, @UCSFMedicine's Sanket Dhruva, @METRICStanford's John Ioannidis, and @YaleDeptEHS's @vasilis…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses…
RT @JoshuaDWallach: W/ @YaleIMed's @jsross119, @UCSFMedicine's Sanket Dhruva, @METRICStanford's John Ioannidis, and @YaleDeptEHS's @vasilis…
W/ @YaleIMed's @jsross119, @UCSFMedicine's Sanket Dhruva, @METRICStanford's John Ioannidis, and @YaleDeptEHS's @vasilisyale, we build upon previous work looking at sex & age subgroup analyses in @cochranecollab reviews. (2/6) https://t.co/wLVEmMcKEm
New @ClinTrialsJ study, led by fantastic @YaleMed student Patrick Liu, suggests that race & ethnicity subgroup analyses in @cochranecollab intervention reviews are rarely planned and almost never conducted. (1/6) https://t.co/grRsqlfwFv Companion pie
https://t.co/LPokdDid3t Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study #cochrane
RT @BMCMedicine: Published this week in @BMCMedicine: Age-treatment subgroup analyses in #Cochrane intervention reviews: a meta-#epidemiolo…
RT @BMCMedicine: Published this week in @BMCMedicine: Age-treatment subgroup analyses in #Cochrane intervention reviews: a meta-#epidemiolo…
RT @JoshuaDWallach: Age subgroup analyses in @cochranecollab intervention reviews are often planned, but rarely conducted (<3%!). Common…
RT @JoshuaDWallach: Age subgroup analyses in @cochranecollab intervention reviews are often planned, but rarely conducted (<3%!). Common…
Age subgroup analyses in @cochranecollab intervention reviews are often planned, but rarely conducted (<3%!). Common obstacle: lack of available age-related information Highlights need for standardization, #transparency, RCT #datasharing etc. https
Published this week in @BMCMedicine: Age-treatment subgroup analyses in #Cochrane intervention reviews: a meta-#epidemiological study https://t.co/WBqQwXiYJX @YaleMed https://t.co/cemiFtcV4R
Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study. https://t.co/vEZB8uDTwL
RT @BMCMedicine: NEW research: Age-treatment subgroup analyses in #Cochrane intervention reviews: a meta-epidemiological study. @YaleMed @S…
RT @BMCMedicine: NEW research: Age-treatment subgroup analyses in #Cochrane intervention reviews: a meta-epidemiological study. @YaleMed @S…
NEW research: Age-treatment subgroup analyses in #Cochrane intervention reviews: a meta-epidemiological study. @YaleMed @StanfordMed @StanfordHumSci @ynhhealth @YaleSPH @UCSFMedicine @DeptVetAffairs @UConn @YaleLawSch @Yale_CRIT https://t.co/6I2Ybnmo6v
Age-treatment subgroup analyses in Cochrane intervention reviews are frequently planned but rarely conducted. Implications of interactions are generally not discussed in the reviews or mentioned in common clinical resources. https://t.co/pxmCzmeCbV @BMCM
New @BMCMedicine paper, led by fantastic @YaleMed student Patrick Liu: We analyzed a large n of @cochranecollab intervention reviews & determined frequency, statistical support, and clinical translation of age subgroup analyses https://t.co/wLVEmMc
RT @JoshuaDWallach: Main findings 1: Among 928 Cochrane intervention reviews of RCTs ~20% had plans to conduct age subgroup analyses...…
Main findings 2: Among 7 subgroup analyses w/ P<0.05 from formal age-treatment interaction test, none were (a) in reviews that discussed the potential clinical/biological rationale/significance and (b) included in common clinical practice guidelines ht
Main findings 1: Among 928 Cochrane intervention reviews of RCTs ~20% had plans to conduct age subgroup analyses... But only ~3% actually conducted age subgroup analyses https://t.co/wLVEmMcKEm (4/7) https://t.co/09hBTjUY3K